3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
BioHarvest Sciences's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 80.66%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for BioHarvest Sciences's 3-Year ROIIC % or its related term are showing as below:
BHST's 3-Year ROIIC % is ranked better than 90.49% of 1830
companies
in the Consumer Packaged Goods industry
Industry Median: 2.89
vs BHST: 80.66
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
BioHarvest Sciences 3-Year ROIIC % Related Terms
BioHarvest Sciences 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for BioHarvest Sciences's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BHST vs BRID, BOF, BFNH: 3-Year ROIIC % Comparison
For the Packaged Foods subindustry, BioHarvest Sciences's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioHarvest Sciences 3-Year ROIIC % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where BioHarvest Sciences's 3-Year ROIIC % falls into.
BioHarvest Sciences's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -5.575 (Dec. 2025) - -10.612 (Dec. 2022) )
/
( 21.296 (Dec. 2025) - 15.051 (Dec. 2022) )
=
5.037
/
6.245
=
80.66%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
BioHarvest Sciences (BHST) has a 3-Year ROIIC % of 80.66 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on BioHarvest Sciences and its competitors. According to the industry distribution chart, BioHarvest Sciences ranks #174 out of 1830 companies in the Consumer Packaged Goods industry, placing it in the top 9.5%.
Is BioHarvest Sciences' 3-Year ROIIC % too high?
BioHarvest Sciences' current 3-Year ROIIC % is 80.66. The Consumer Packaged Goods industry median 3-Year ROIIC % is 2.89. BioHarvest Sciences' value of 80.66 is 2691% above this industry median. Based on the distribution chart, BioHarvest Sciences ranks #174 out of 1830 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, BioHarvest Sciences has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' 3-Year ROIIC % compare to BRID and BOF?
According to the Consumer Packaged Goods industry distribution chart, BioHarvest Sciences ranks #174 out of 1830 companies for 3-Year ROIIC %. This places BioHarvest Sciences in the top 10% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 2.89. BioHarvest Sciences' value of 80.66 is 2691% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Consumer Packaged Goods company?
The median 3-Year ROIIC % among Consumer Packaged Goods companies is 2.89, based on 1,830 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioHarvest Sciences's current 3-Year ROIIC % of 80.66 is 2691% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on BioHarvest Sciences and its competitors. For the Consumer Packaged Goods industry, the median 3-Year ROIIC % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioHarvest Sciences's current 3-Year ROIIC % is 80.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.58, compared to a current price of $3.00 — trading 65% below its estimated fair value. The current 3-Year ROIIC % is 80.66 and 2691% above the Consumer Packaged Goods industry median of 2.89. BioHarvest Sciences' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current 3-Year ROIIC % is 80.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioHarvest Sciences (BHST) Overvalued in 2026?
Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued.
The current stock price of $3.00 is trading 65% below its estimated GF Value™ of $8.58.
GuruFocus considers BioHarvest Sciences to be Possible Value Trap.
Key valuation signals for BHST:
3-Year ROIIC %: 80.66
GF Value™: $8.58 vs. price of $3.00 (65% below fair value)
Industry Position: 2691% above the Consumer Packaged Goods median (#174 of 1830)
No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
63GF Score
Get the complete analysis for BHST
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHST has been successfully added to your 
